Jane Street Group, LLC Catalyst Biosciences, Inc. Transaction History

Jane Street Group, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.49 - $0.57 $15,338 - $17,842	31,303 New	31,303 $16,000
Q1 2022 May 17, 2022	SELL	$0.51 - $1.0 $8,863 - $17,379	-17,379 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$0.91 - $4.16 $15,814 - $72,296	17,379 New	17,379 $16,000
Q2 2021 Aug 16, 2021	SELL	$4.1 - $5.33 $47,268 - $61,449	-11,529 Closed	0 $0
Q1 2021 May 18, 2021	BUY	$4.93 - $7.15 $56,837 - $82,432	11,529 New	11,529 $58,000
Q4 2020 Feb 17, 2021	SELL	$4.55 - $7.29 $167,349 - $268,126	-36,780 Closed	0 $0
Q3 2020 Nov 17, 2020	BUY	$4.22 - $6.04 $81,011 - $115,949	19,197 Added 109.18%	36,780 $158,000
Q2 2020 Aug 17, 2020	BUY	$3.76 - $8.01 $66,112 - $140,839	17,583 New	17,583 $103,000
Q3 2019 Nov 14, 2019	SELL	$4.91 - $9.31 $71,361 - $135,311	-14,534 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$7.08 - $10.6 $102,900 - $154,060	14,534 New	14,534 $107,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.